Healthcare
Phio Pharma
Recorded February 5, 2026
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
Boost Fertility is on a mission to ensure clinical-grade infertility treatment is affordable and available for anyone who wants it.
Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
Boost Fertility is on a mission to ensure clinical-grade infertility treatment is affordable and available for anyone who wants it.
Araceli Biosciences is poised to become the backbone of next-generation drug discovery and AI-driven therapeutics.
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
Coretag has built a patented Tumor Necrosis Targeting Platform that can be used across many solid cancers.
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
Coretag has built a patented Tumor Necrosis Targeting Platform that can be used across many solid cancers.